Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure [Phase 1, Phase 2]
Phase 1/2 trial update evaluating the safety, efficacy, and pharmacokinetics of DNB-001 in subjects with elevated intraocular pressure, incl…
-
CLINICAL_TRIALS trial_result · 2009-05-29Clinical Trial Update: MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED) [Phase 3]
Phase 3 study MK0507A in glaucoma (and ocular hypertension) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH). [Phase 3]
Phase 3 trial comparing Xalacom and Xalatan in primary open-angle glaucoma or ocular hypertension completed with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-03-16Clinical Trial Update: Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
DE-104 ophthalmic solution completed a Phase 2 safety and efficacy study in open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2009-03-16Clinical Trial Update: To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 clinical trial evaluating DE-104 ophthalmic solution for open-angle glaucoma or ocular hypertension has completed. The study was s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-01-14Clinical Trial Update: Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial comparing fixed-dose combinations brimonidine/timolol and dorzolamide/timolol in open-angle glaucoma or ocular hypertension ha…
-
CLINICAL_TRIALS trial_result · 2009-01-14Clinical Trial Update: Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
A Phase 4 trial comparing fixed combinations brimonidine/timolol and dorzolamide/timolol in patients with open-angle glaucoma or ocular hype…
-
CLINICAL_TRIALS trial_result · 2009-01-12Clinical Trial Update: Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops [Phase 3]
Phase 3 trial update assessing ocular signs and symptoms when glaucoma patients switch from latanoprost to preservative-free tafluprost eye …
-
CLINICAL_TRIALS trial_result · 2009-01-07Clinical Trial Update: Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma [Phase 1, Phase 2]
Phase 1-2 clinical trials evaluated OT-730 Eye Drops for reducing intraocular pressure in adults with ocular hypertension or open-angle glau…
-
CLINICAL_TRIALS trial_result · 2008-12-05Clinical Trial Update: Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative
A completed clinical trial comparing dry eye and irritation outcomes when latanoprost with preservative is used versus preservative-free tra…
-
CLINICAL_TRIALS trial_result · 2008-12-04Clinical Trial Update: Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) [Phase 4]
Phase 4 trial comparing Istalol 0.5% once daily with Brimonidine tartrate 0.1% twice daily as add-on therapy to latanoprost in adults with o…
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: Cosopt Versus Xalacom [Phase 4]
A Phase 4 trial comparing Cosopt with Xalacom in open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: Assessing Cosopt Switch Patients [Phase 4]
Phase 4 clinical trial completed evaluating outcomes for patients switched to Cosopt (dorzolamide-timolol) in ocular hypertension and severa…
-
CLINICAL_TRIALS trial_result · 2008-11-05Clinical Trial Update: A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension [Phase 3]
This document reports the completion of a 5-year postmarketing safety study of Xalcom in patients with open-angle glaucoma or ocular hyperte…
-
CLINICAL_TRIALS trial_result · 2008-10-28Clinical Trial Update: Intraocular Pressure With Loteprednol and Dexamethasone [Phase 4]
Phase 4 clinical trial evaluating intraocular pressure effects of loteprednol and dexamethasone in open-angle glaucoma and ocular hypertensi…
-
CLINICAL_TRIALS trial_result · 2008-09-26Clinical Trial Update: Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% [Phase 4]
A Phase 4 trial comparing bimatoprost 0.03% with travoprost 0.004% in patients already using latanoprost, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 [Phase 3]
A Phase 3 clinical trial sponsored by Alcon Research evaluating an intraocular pressure-lowering therapy for open-angle glaucoma and ocular …
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma [Phase 3]
A Phase 3 study compared travoprost 0.004% to latanoprost 0.005% in patients with chronic angle-closure glaucoma to evaluate safety and effi…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients [Phase 2]
A Phase II safety and efficacy trial evaluating a glaucoma therapy in open-angle glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Phase 3]
A Phase 3 head-to-head trial comparing Travoprost 0.004% with Latanoprost 0.005% in open-angle glaucoma and ocular hypertension has complete…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) [Phase 3]
A Phase 3 study comparing Travatan (travoprost) to Xalcom over six weeks evaluated safety and efficacy in adults with open-angle glaucoma or…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98 [Phase 3]
Phase 3 trial in Japanese subjects evaluating IOP lowering in open-angle glaucoma or ocular hypertension, sponsored by Alcon Research; study…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase III clinical trial of brimonidine tartrate ophthalmic solution 0.15% in open-angle glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial update investigating the mechanism of action of Travatan 0.004% in people with glaucoma or ocular hypertension. The study stat…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70 [Phase 3]
A Phase 3 clinical trial evaluating an intraocular pressure-lowering therapy for open-angle glaucoma and ocular hypertension has completed.